July 6, 2017

International AIDS Society announces Dr Kenneth Mayer is new JIAS Editor-in-Chief

Written by International AIDS Society

This article originally appeared on IAS’s website. Reposted with permission.

20 June 2017 (Geneva, Switzerland) – The International AIDS Society (IAS) announced today that Dr Kenneth Mayer is a new Editor-in-Chief of the Journal of the International AIDS Society (JIAS).

Dr Mayer, who joined the JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed publications. Among his other accomplishments, he is the founding Medical Research Director of Fenway Health and Co-Chair of The Fenway Institute, a member of the US President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board, amfAR’s Program Advisory Council, and a member of the International AIDS Society (IAS) Governing Council.

“Ken is an extremely well respected clinician and researcher who I have had the pleasure to work with for many years,” IAS President Linda-Gail Bekker said. “Under his leadership, the high standards of the JIAS brand to publish quality research will continue to grow and develop. I can’t imagine anybody else who is more suited for the role.”

Dr Mayer trained in Internal Medicine at Beth Israel Hospital (1977-80) and in Infectious Diseases and Molecular Epidemiology at Brigham and Women’s Hospital (1980-83).

At Fenway Health, he created a community health research programme that now has an international reputation for its capability to conduct community-based research under the umbrella of The Fenway Institute. He is currently a Professor at Harvard Medical School, a Professor in Global Health and Population at the Harvard TC Chan School of Public Health, and Attending Physician and Director of HIV Prevention Research at Beth Israel Deaconess Medical Center in Boston.

Since 1994, he has been a Principal Investigator of National Institute of Health (NIH)-funded HTVN, HPTN, MTN and ATN clinical trials units, focusing on bio-behavioural HIV prevention research. He has served on the national boards of amfAR, HIVMA and GLMA, was a member of the CDC/HRSA HIV/AIDS Advisory Committee, was a member of the IOM panel evaluating metrics to assess the U.S. National HIV/AIDS Strategy, and is currently a member of the PCORI Addressing Disparities Advisory Board. His work has been recognized by the Commonwealth of Massachusetts, the American College of Physicians, and several U.S. educational institutions, including the University of Pennsylvania (his alma mater).

“As a long-time supporter of and contributor to JIAS, I take this appointment with great enthusiasm,” Dr Mayer said. “I look forward to building upon its legacy and working with the team to expand the essential role that JIAS plays in promoting and disseminating HIV research.”

Mayer is filling the role of previous Editor-in-Chief, Prof Mark Wainberg, who passed away in April 2017. Dr Mayer will be joining the JIAS co-Editors-in-Chief, Susan Kippax and Papa Salif Sow. JIAS is one of the leading journals in the HIV field, ranking in the top 10 “Infectious diseases” journals and 25 “Immunology” journals, receiving over 600 submissions per year.